Key Takeaways
The FDA advisory panel unanimously endorsed donanemab, Eli Lilly’s monoclonal antibody drug for early-stage Alzheimer’s disease.Clinical trials showed that donanemab slowed Alzheimer’s...
June 11, 2024
The U.S. Department of Defense (DoD) recently submitted a budget request for the cleanup of per- and polyfluoroalkyl substances (PFAS)...